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Abstract
Matrix-assisted laser desorption ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS) initiated a revolution in the identiﬁca-
tion of organisms grown on solid medium, including bacteria and fungi. Rapid identiﬁcation of organisms responsible for septicaemia,
which are typically grown in broth, is now expanding the ﬁeld of application. Despite the fact that there are fewer than ten reports in
the literature, published data indicate that MALDI-TOF MS yields accurate identiﬁcation of blood-borne organisms in ‡80% of cases for
inocula of >107 organisms/mL. A major current limitation is failure to accurately identify Streptococcus pneumoniae among viridans step-
tococci. Identiﬁcation is achieved in <2 h, sharply reducing the turn-around time for communication of identiﬁcation to the clinician.
Further progress in handling protocols and automation, and extraction of antibiotic resistance data from the MALDI-TOF MS spectra,
will further push this emerging approach as the standard one in the laboratory diagnosis of septicaemia, paving the way to application in
further clinical situations and clinical specimens.
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Introduction
The rapid detection and identiﬁcation of bacteria in clinical
blood specimens has been advocated in order to shorten the
turn-around time for appropriate management of patients
suffering from septicaemia [1,2]. Although the automated
blood culture systems have indeed reduced the delay in
detecting the presence of blood-borne bacteria and fungi,
identiﬁcation of such organisms still relies on microscopic
examination of the organism morphology after Gram staining
and further identiﬁcation after subculturing of the organism
on a solid support. Direct detection and identiﬁcation of
such organisms with the use of real-time PCR and a com-
mercialized system yielded encouraging, but limited, results
[3–5]. However, Gram staining lacks both speciﬁcity, because
of false-positive results resulting from technical limitation and
limited expertise of the reader, and because a true-positive
result may not provide the clinician with enough information
for accurate adaptation of the antibiotic treatment [6].
Furthermore, relying on subculture for the identiﬁcation
delays such identiﬁcation by 12–72 h. Direct inoculation of
the positive blood culture broth into identiﬁcation automat
has been proposed, but this procedure was limited to Gram-
negative rods [7]. Direct hybridization of the positive blood
culture broth with probes in the ﬂuorescence in situ hybrid-
ization technique is limited to the identiﬁcation of one or a
few determined bacterial species [8–10]. Various PCR-based
techniques, including real-time PCR and pyrosequencing [11],
have been developed to speed the identiﬁcation of blood-
borne bacteria, and a commercially available real-time PCR
has been introduced for the direct detection of bacteria in
blood [4], but no such solution has actually been imple-
mented as a routine technique in clinical microbiology labo-
ratories.
Matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry (MS) has emerged as a
potent tool for the rapid identiﬁcation of bacteria and
yeast grown on solid medium, comparing favourably with
Gram staining [12]. In this situation, organisms form colo-
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nies that are easily detached from the medium surface,
and MS analysis can be performed without any further
preparation in most cases of bacterial identiﬁcation [13].
For fungi, rapid treatment by ethanol washing and protein
extraction with formic acid and acetonitrile (AN) or pre-
treatment with triﬂuoroacetic acid (TFA) has been pro-
posed in order to standardize MALDI-TOF MS
identiﬁcation [14,15]. Organisms grown in blood culture
broth have to be separated from the liquid phase and
from the red cells to prevent interference during the
MALDI-TOF MS analysis.
Protocols
There are a few reports indicating the possibility of direct
identiﬁcation of bacteria in blood culture specimens [16–21].
In these studies, the detection of organisms was performed
with automated blood culture systems, and the identiﬁcation
of detected organisms was performed by MALDI-TOF MS
analysis. In this situation, the organisms grew in a liquid med-
ium of complex composition, owing to the presence of both
medium proteins and the red blood cells. Therefore, in con-
trast to what happens with most cultured organisms, which
are deposited onto the MS plate without any further
preparation [22], organisms grown on liquid medium do have
to be prepared before the MALDI-TOF MS analysis, using
various protocols [16–18]. In particular, the haemoglobin
must be discarded, as it yields strong peaks that hamper the
interpretation of speciﬁc peaks (Fig. 1). Basically, these
protocols comprise four steps: (i) specimen collection;
(ii) removal of red cells; (iii) protein precipitation; and
(iv) protein extraction and solubilization (Fig. 2).
Positive blood culture broth is collected immediately after
the positive vial is taken out of the automat [16,17] or after
the positive vial has been held for 3–10 h at room tempera-
ture [18], and 0.2–5 mL of blood culture broth is collected
into a standard sterile tube [16,17] or into a serum separa-
tor tube with a clot activator [18].
Red blood cells are further removed by combining cell
lysis, by using distilled water [13], ammonium chloride
[17,18] or saponin [19], and low-speed centrifugation and
sterile water washing. Washing also allows the elimination of
blood and broth proteins, including blood albumin. SDS has
been used in the particular case of Candida spp. [21]. Pro-
teins are further precipitated by washing with 70% ethanol
[17,18], and are further solubilized and extracted by incuba-
tion in the presence of TFA combined with AN [16], or for-
mic acid combined with AN [16,18] or TFA [21].
Comparison of the latter protocols indicated that the
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FIG. 1. Identiﬁcation of bacteria in positive blood culture broth: process overview.
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combination of formic acid with AN was superior to the
combination of TFA with AN [16].
The following steps are not speciﬁc, and comprise MALDI-
TOF MS plate deposition, matrix deposition and drying, and
MS analysis, with the exception that absolute ethanol can be
poured onto spots before the matrix is added (Fig. 2). Bacte-
rial proteins are spotted onto a MALDI-TOF MS MTP (MALDI
target plate) plate, overlaid with 2 lL of matrix solution (satu-
rated solution of a-cyano-4-hydroxycinnamic acid in 50% AN
and 2.5% TFA), and crystallized by air-drying at room tempera-
ture before protein analysis by MS.
Performance
Three studies have investigated the performance of MALDI-
TOF MS for the identiﬁcation of bacteria in positive blood
culture broths [16–18] (Table 1). It must be noted that the
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FIG. 2. Confusing haemoglobin peaks (*) in matrix-assisted laser desorption ionization time-of-ﬂight mass (MALDI-TOF) mass spectrometry
analysis of blood-borne organisms.
TABLE 1. Performance in identifying bacteria in positive blood culture broth
Nature of specimen
(n = number of specimens) Organism
Percentage of
interpretable
spectra (%)
Percentage
of correct
identiﬁcation:
genus level (%)
Percentage
of correction
identiﬁcation:
species level (%)
Major identiﬁcation
failures References
Positive blood culture broth (n = 599) Bacteria 94 76 76 Streptococcus spp. 16
Positive blood culture broth (n = 126) Bacteria 97 79 57 Streptococcus pneumoniae 17
Positive blood culture broth (n = 179)
Spiked bottles (n = 33)
Bacteria 100a 80a 80a S. pneumoniae
Propionibacterium acnes
18
Spiked bottles (n = 312) Bacteria 98 98 89 S. pneumoniae
Positive blood culture broth (n = 388) Candida spp. 96 98 91 S. pneumoniae 19
Positive blood culture broth (n = 304) Bacteria 94.7 87 87 Uncommon species 20
Spiked bottles (n = 48) Candida spp. 100 100 100 –
Positive blood culture broth (n = 1) Candida albicans 100 100 100 – 21
aIncluding spiked bottles.
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performance obtained with bottles artiﬁcially seeded with
microorganisms may not reﬂect the actual performance
obtained in routine detection, probably because of the varia-
tions in the inoculum, as discussed below (Table 1). Likewise,
there is no evidence suggesting that the broth had an impact
on the performance of MALDI-TOF MS identiﬁcation; four of
ﬁve studies used the Bactec 9240 (Becton Dickinson, Le Pont-
de-Claix, France) apparatus and either standard aerobic/anaer-
obic broths [18] or the Bactec Plus broths [17,20], whereas
one study used the Bact/Alert (BioMe´rieux, Marcy-l’E´toile,
France) apparatus [19]. With regard to identiﬁcation of bacte-
ria detected in blood culture bottles, a 5-month study analysed
584 positive blood cultures, including 562 specimens contain-
ing a single bacterial species and 22 specimens containing more
than one bacterial species [16]. This study found a clear differ-
ence in the identiﬁcation of Gram-negative and Gram-positive
organisms, with 94% of Gram-negative organisms being
identiﬁed and only 67% of Gram-positive organisms being
identiﬁed. In particular, this study found that viridans strepto-
cocci were not identiﬁed at all. The study also found that the
use of AN for the preparation of the specimen was deleterious
[16]. A further 9-week study indicated that an identiﬁcation
could be obtained in 78.7% of 122 positive blood cultures,
including identiﬁcation at the species level in 98.95% of cases
and identiﬁcation at the genus level in the remaining case.
Identiﬁcation failure was observed mainly for Streptococcus and
Staphylococcus. A clear limitation was the failure to identify
8/10 Streptococcus pneumoniae isolates; the two other
S. pneumoniae isolates were identiﬁed at the species level,
albeit with a low score [17]. Also, the encapsulated organisms
Klebsiella pneumoniae and Haemophilus inﬂuenzae were among
the few Gram-negative organisms exhibiting a low (<1.7)
identiﬁcation score [17], a limitation that had not been
observed in the previous study (26/28 well-identiﬁed K. pneu-
moniae isolates and 1/3 well-identiﬁed H. inﬂuenzae isolates)
[16]. A third study of a total of 212 positive cultures was
examined, representing 32 genera and 60 species or groups.
The identiﬁcation of bacterial isolates by MALDI-TOF MS was
compared with biochemical testing, and discrepancies were
resolved by gene sequencing. No identiﬁcation (spectral score
of <1.7) was obtained for 42 (19.8%) of the isolates, most
commonly because of insufﬁcient numbers of bacteria in the
blood culture broth. Among the bacteria with a spectral score
of ‡1.7, 162 (95.3%) of 170 isolates were correctly identiﬁed.
All eight isolates of Streptococcus mitis were misidentiﬁed as
S. pneumoniae isolates. This method provides a rapid, accurate,
deﬁnitive identiﬁcation of bacteria within 1 h of detection in
positive blood cultures, with the caveat that the identiﬁcation
of S. pneumoniae would have to be conﬁrmed by an alternative
test [18]. In bottles spiked with bacteria, Staphylococcus aureus
was distinguished from non-aureus staphylococci in 100% of
cases [19]. In bottles spiked with S. pneumoniae/S. mitis
organisms, agglutination correctly identiﬁed S. pneumoniae
organisms [19].
A delay of 20 min has been measured once the blood
culture bottle has been detected positive [19]. Another
study found an overall turn-around time of 75–140 min, with
a hands-on time of 10–70 min [20].
Unresolved Issues
The identiﬁcation of viridans Streptococcus spp. organisms in
blood culture bottles remains problematic in most studies
[16,17], in agreement with previous observations made with
the use of agar medium-grown colonies [13]. Pooling of data
from currently published reports indicates that 16/20 (80%)
S. pneumoniae strains were not identiﬁed solely by MALDI-
TOF MS. The lack of an appropriate database may partially
explain this fact, which also illustrates difﬁculties in the tax-
onomy of this particular group of organisms. Therefore,
complementation of the MALDI-TOF MS identiﬁcation with
an agglutination test is mandatory in the case of viridans
Streptococcus sp. identiﬁcation.
Identifying mixed organisms in the same blood culture
specimen remains problematic. In one study, 15 mixed bacte-
ria bottles were tested, and yielded one or two bacteria; the
authors observed that use of a speciﬁc database improved
the identiﬁcation score [19]. Most studies report that only
one of the two organisms is identiﬁed by MALDI-TOF MS
[17,20]; moreover, mixed ﬂora may result in a lack of identi-
ﬁcation or false species identiﬁcation [16].
The optimal protocol for blood culture broth processing
remains to be determined and evaluated; every one of the
six major available studies listed its own protocol. Compa-
nies will probably develop and sell their own solutions for
red cell lysis and protein extraction, thus standardizing the
blood specimen processing and paving the way towards an
automated process. Also, the optimization of laboratory
processes, combined with the use of last-generation mass
spectrometers and software, would further reduce the turn-
around time for identiﬁcation of blood-borne organisms.
Mass spectrometers are, indeed, amenable to integration into
an semi-automated or fully automated laboratory.
Future Directions
The capacity of MALDI-TOF MS to identify organisms in blood
clearly depends on the inoculum [19]. Spiking experiments
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with Staphylococcus aureus and Escherichia coli indicated that
organisms present at 107–108 CFU/mL were correctly
identiﬁed, whereas 106 CFU/mL yielded signals that were
indistinguishable from the background of negative controls,
indicating that it was necessary to deposit at least 104–
105 CFU on the plate in order to obtain an identifying spec-
trum [20]. In that study, it was determined that a positive
blood culture broth contained a median of 108 organisms/mL
[20]. Increasing the sensitivity of MALDI-TOF MS detection
may open the way to the fast, direct detection and identiﬁca-
tion of blood-borne organisms and introduction of the pro-
cedure for point-of-care diagnosis of septicaemia after
bedside collection of blood. The nature of the MALDI-
TOF MS plate was not always precisely deﬁned in reports;
nevertheless, testing additional MALDI-TOF MS plates may
increase the sensitivity of identiﬁcation. Also, further analysis
and interpretation of MALDI-TOF MS spectra derived from
blood-borne organisms may provide information about anti-
biotic resistance [23] or phenotypic traits such as the Pan-
ton–Valentine toxin in Staphylococcus aureus [24], which
directly inﬂuence the choice of optimal antibiotic treatment.
The expertise gained in studying blood-borne bacteria may
prompt further studies on the detection and identiﬁcation of
bacteria in other normally sterile ﬂuids. One study [19]
addressed this topic by inoculating 46 ﬂuids, including graft
conservation liquid, joint ﬂuid, deep abscess specimens and
bone puncture specimens, in blood culture broth, and found
that 44/46 (96%) were identiﬁed at the species level, the
remaining two being identiﬁed at the genus level [19]. Such
encouraging results should prompt further studies on the rapid
MALDI-TOF MS identiﬁcation of microorganisms in normally
sterile ﬂuids such as urine, with or without an enrichment step.
Finally, the true impact on the management of patients of
decreasing the delay in communication of positive blood cul-
ture by the use of MALDI-TOF MS technology remains to
be evaluated, as data obtained with previous methods are
somewhat contradictory.
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